Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.

Xinqing LinTingting LuHaiyi DengChunxin LiuYilin YangTao ChenYinyin QinXiaohong XieZhanhong XieMing LiuMing OuyangShiyue LiYong SongNanshan ZhongWei QiuCheng-Zhi Zhou

Published in: Journal of neurology (2021)

Serum NfL and GFAP could be potential diagnostic biomarkers for BM in patients with lung cancer. We established a model that can provide individual diagnoses of BM. Higher NfL level may be associated with poor prognosis of patients with BM.

Keyphrases

poor prognosis
brain metastases
long non coding rna
small cell lung cancer
cerebrospinal fluid
neuropathic pain
risk assessment
human health
ionic liquid
small molecule
spinal cord
binding protein